title: Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.
abstract: Although cholecystokinin (CCK) has long been known to exert anxiogenic effects in both animal anxiety models and humans, the underlying cellular and molecular mechanisms are ill-defined. CCK interacts with CCK-1 and CCK-2 receptors resulting in up-regulation of phospholipase C (PLC) and protein kinase C (PKC). However, the roles of PLC and PKC in CCK-mediated anxiogenic effects have not been determined. We have shown previously that CCK facilitates glutamate release in the hippocampus especially at the synapses formed by the perforant path and dentate gyrus granule cells via activations of PLC and PKC. Here we further demonstrated that CCK enhanced NMDA receptor function in dentate gyrus granule cells via activation of PLC and PKC pathway. At the single-channel level, CCK increased NMDA single-channel open probability and mean open time, reduced the mean close time, and had no effects on the conductance of NMDA channels. Because elevation of glutamatergic functions results in anxiety, we explored the roles of PLC and PKC in CCK-induced anxiogenic actions using the Vogel Conflict Test (VCT). Our results from both pharmacological approach and knockout mice demonstrated that microinjection of CCK into the dentate gyrus concentration-dependently increased anxiety-like behavior via activation of PLC and PKC. Our results provide a novel unidentified signaling mechanism whereby CCK increases anxiety.
authors.affiliation: Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58203, USA.
authors.forename: Zhaoyang
authors.initials: Z
authors.lastname: Xiao
authors.forename: Manoj K
authors.initials: MK
authors.lastname: Jaiswal
authors.forename: Pan-Yue
authors.initials: PY
authors.lastname: Deng
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Matsui
authors.forename: Hee-Sup
authors.initials: HS
authors.lastname: Shin
authors.forename: James E
authors.initials: JE
authors.lastname: Porter
authors.forename: Saobo
authors.initials: S
authors.lastname: Lei
mesh_terms: D000818:Animals; D001007:Anxiety / Q000139:chemically induced* / Q000201:enzymology*; D002766:Cholecystokinin / Q000008:administration & dosage* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D005260:Female; D015640:Ion Channel Gating / Q000502:physiology; D008297:Male; D051379:Mice; D057507:Mice, 129 Strain; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008845:Microinjections; D011493:Protein Kinase C / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology*; D010738:Type C Phospholipases / Q000502:physiology*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D002766:Cholecystokinin; D011493:Protein Kinase C; D010738:Type C Phospholipases
references.citation: J Neurosci. 1984 Apr;4(4):1021-33
references.pmid: 6325601
references.citation: J Neurosci. 2001 Nov 1;21(21):8464-72
references.pmid: 11606635
references.citation: Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):9-15
references.pmid: 11420063
references.citation: Biol Psychiatry. 2002 Nov 15;52(10):1008-30
references.pmid: 12437941
references.citation: Neurosci Biobehav Rev. 2005;29(8):1361-73
references.pmid: 16120463
references.citation: Hippocampus. 2004;14(7):849-60
references.pmid: 15382255
references.citation: Regul Pept. 2000 Sep 25;93(1-3):79-83
references.pmid: 11033055
references.citation: J Neurosci. 2010 Jan 6;30(1):242-54
references.pmid: 20053906
references.citation: Physiol Behav. 2005 Apr 13;84(5):775-82
references.pmid: 15885255
references.citation: J Neurophysiol. 2007 Jan;97(1):727-37
references.pmid: 17135466
references.citation: Nat Rev Neurosci. 2010 Oct;11(10):682-96
references.pmid: 20842175
references.citation: J Comp Neurol. 1981 Dec 10;203(3):335-50
references.pmid: 7320233
references.citation: Nat Neurosci. 2001 Apr;4(4):382-90
references.pmid: 11276228
references.citation: Trends Pharmacol Sci. 2008 Oct;29(10):493-8
references.pmid: 18755516
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11825-30
references.pmid: 8876222
references.citation: J Neurosci. 1997 Jul 1;17(13):4994-5003
references.pmid: 9185537
references.citation: Psychopharmacology (Berl). 1996 Dec;128(4):380-97
references.pmid: 8986009
references.citation: J Neurosci. 1987 Sep;7(9):2967-76
references.pmid: 3625281
references.citation: Neurosci Lett. 2009 Jan 2;449(1):34-7
references.pmid: 18983894
references.citation: Mol Psychiatry. 2010 Jun;15(6):574-88
references.pmid: 20010888
references.citation: Prog Neurobiol. 1999 Jul;58(4):349-79
references.pmid: 10368033
references.citation: J Physiol. 2002 Dec 15;545(3):903-11
references.pmid: 12482895
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):242-9
references.pmid: 15608072
references.citation: Behav Brain Res. 2011 Jul 7;220(2):305-11
references.pmid: 21316396
references.citation: Am J Physiol. 1995 Nov;269(5 Pt 1):G628-46
references.pmid: 7491953
references.citation: J Neurosci. 1999 Aug 15;19(16):7230-7
references.pmid: 10436075
references.citation: Pharmacol Rev. 1999 Mar;51(1):7-61
references.pmid: 10049997
references.citation: Neurosci Lett. 1987 Sep 23;80(2):191-6
references.pmid: 3683976
references.citation: Peptides. 1994;15(4):731-55
references.pmid: 7937354
references.citation: Eur J Neurosci. 1998 Jun;10(6):2016-25
references.pmid: 9753089
references.citation: Trends Neurosci. 1993 Sep;16(9):359-65
references.pmid: 7694406
references.citation: Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):78-84
references.pmid: 11483244
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13355-60
references.pmid: 11687615
references.citation: Neuropeptides. 1997 Jun;31(3):281-5
references.pmid: 9243526
references.citation: Ann N Y Acad Sci. 1994 Mar 23;713:273-82
references.pmid: 8185169
references.citation: Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1130-3
references.pmid: 1996314
references.citation: Can J Psychiatry. 1990 Feb;35(1):83-5
references.pmid: 2180549
references.citation: Ann N Y Acad Sci. 2009 Oct;1179:120-43
references.pmid: 19906236
references.citation: Neuron. 2009 Jul 30;63(2):230-43
references.pmid: 19640481
references.citation: Neuropharmacology. 2008 Jan;54(1):117-28
references.pmid: 17689570
references.citation: J Neurochem. 2008 Jan;104(1):1-13
references.pmid: 17971128
references.citation: J Neurosci. 2001 Aug 15;21(16):6058-68
references.pmid: 11487629
references.citation: Eur Neuropsychopharmacol. 2004 May;14(3):175-83
references.pmid: 15056476
references.citation: J Neurosci. 1990 Apr;10(4):1070-81
references.pmid: 2329368
references.citation: Pharmacol Biochem Behav. 1995 Dec;52(4):701-6
references.pmid: 8587908
references.citation: J Comp Neurol. 1982 Sep 10;210(2):136-46
references.pmid: 6290546
references.citation: Biol Psychiatry. 1998 Nov 1;44(9):915-7
references.pmid: 9807648
references.citation: Neurosci Lett. 1988 Jul 19;90(1-2):51-6
references.pmid: 3412648
references.citation: Curr Psychiatry Rep. 2008 Dec;10(6):510-9
references.pmid: 18980735
references.citation: J Neural Transm (Vienna). 2011 Nov;118(11):1559-69
references.pmid: 21499940
references.citation: J Clin Psychiatry. 2003;64 Suppl 3:28-35
references.pmid: 12662131
references.citation: J Neurosci. 2010 Apr 14;30(15):5136-48
references.pmid: 20392936
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):178-85
references.pmid: 17804134
references.citation: Behav Genet. 2000 Mar;30(2):111-21
references.pmid: 10979601
references.citation: Exp Brain Res. 1998 Nov;123(1-2):77-83
references.pmid: 9835394
references.citation: Neuropharmacology. 1994 Jun;33(6):737-43
references.pmid: 7936111
references.citation: Psychopharmacology (Berl). 2010 Oct;212(2):251-65
references.pmid: 20645079
references.citation: J Neurochem. 2001 Feb;76(3):737-44
references.pmid: 11158244
references.citation: Hippocampus. 2008;18(8):824-34
references.pmid: 18493969
references.citation: Nat Neurosci. 2007 Jul;10(7):896-902
references.pmid: 17558402
references.citation: J Comp Neurol. 1988 Oct 8;276(2):219-30
references.pmid: 3220981
references.citation: J Neurosci. 2002 Mar 15;22(6):2153-64
references.pmid: 11896155
references.citation: Annu Rev Neurosci. 1994;17:31-108
references.pmid: 8210177
references.citation: Mol Cell Neurosci. 2011 Dec;48(4):308-20
references.pmid: 21600287
references.citation: Life Sci. 2006 Nov 2;79(23):2238-44
references.pmid: 16914165
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3881-6
references.pmid: 16537459
references.citation: Neuropharmacology. 2009 Jan;56(1):47-55
references.pmid: 18789340
references.citation: Brain Res. 1994 Mar 21;640(1-2):81-92
references.pmid: 8004467
references.citation: Trends Neurosci. 2002 Nov;25(11):571-7
references.pmid: 12392932
references.citation: Neuron. 2006 Feb 16;49(4):589-601
references.pmid: 16476667
references.citation: Nat Neurosci. 2005 Oct;8(10):1319-28
references.pmid: 16158066
references.citation: Brain Res. 2005 Oct 12;1059(1):46-51
references.pmid: 16168394
references.citation: J Neurophysiol. 1998 Jul;80(1):113-9
references.pmid: 9658033
references.citation: Psychopharmacology (Berl). 2007 Dec;195(2):183-92
references.pmid: 17661019
references.citation: Psychopharmacology (Berl). 2000 Sep;152(1):55-66
references.pmid: 11041316
references.citation: Curr Drug Targets. 2001 Sep;2(3):299-312
references.pmid: 11554554
references.citation: J Physiol. 2006 Dec 1;577(Pt 2):497-511
references.pmid: 16990402
references.citation: Nat Neurosci. 1999 Apr;2(4):331-8
references.pmid: 10204539
references.citation: Brain Res. 1981 May 11;212(1):51-7
references.pmid: 7225864
references.citation: J Neurosci. 2005 Dec 7;25(49):11374-84
references.pmid: 16339032
references.citation: Nature. 1997 Sep 18;389(6648):290-3
references.pmid: 9305844
references.citation: Neurosci Lett. 1997 Sep 26;234(1):67-70
references.pmid: 9347948
references.citation: Crit Rev Neurobiol. 1995;9(4):345-69
references.pmid: 8829850
references.citation: Brain Res. 1986 Jan 1;362(1):175-9
references.pmid: 3002550
references.citation: Peptides. 2001 Aug;22(8):1197-200
references.pmid: 11457511
references.citation: J Neurophysiol. 2007 Nov;98(5):2868-77
references.pmid: 17804573
references.citation: J Mol Neurosci. 2010 Nov;42(3):319-26
references.pmid: 20414742
references.citation: Eur J Pharmacol. 2006 Feb 15;531(1-3):183-6
references.pmid: 16455072
references.citation: Neuropharmacology. 2001 Jun;40(7):856-65
references.pmid: 11378156
references.citation: Neuron. 2003 Jul 31;39(3):401-7
references.pmid: 12895416
references.citation: Nat Neurosci. 2007 Sep;10(9):1128-30
references.pmid: 17676058
references.citation: J Physiol. 2006 Apr 15;572(Pt 2):425-42
references.pmid: 16455686
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(17):6728-32
references.pmid: 1975695
references.citation: J Biol Chem. 2011 Aug 12;286(32):28331-42
references.pmid: 21676872